Business Description
Laboratorio Reig Jofre SA
ISIN : ES0165359029
Total Employee Number:
1,512Compare
Compare
Traded in other countries / regions
RJF.Spain0RB1.UKFEQ1.Germany IPO Date
2007-04-27Description
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 2.58 | |||||
Interest Coverage | 4.34 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.91 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | 1 | |||||
3-Year EPS without NRI Growth Rate | -5.9 | |||||
3-Year Book Growth Rate | 2.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 36.68 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.13 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.61 | |||||
9-Day RSI | 51.39 | |||||
14-Day RSI | 51.59 | |||||
3-1 Month Momentum % | -1.89 | |||||
6-1 Month Momentum % | 1.96 | |||||
12-1 Month Momentum % | -4.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 157.99 | |||||
Days Sales Outstanding | 59.02 | |||||
Days Payable | 106.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.91 | |||||
Dividend Payout Ratio | 0.2 | |||||
3-Year Dividend Growth Rate | 7 | |||||
Forward Dividend Yield % | 0.91 | |||||
5-Year Yield-on-Cost % | 1.02 | |||||
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -13.76 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 60.18 | |||||
Operating Margin % | 3.3 | |||||
Net Margin % | 1.79 | |||||
EBITDA Margin % | 11.42 | |||||
FCF Margin % | -4.13 | |||||
OCF Margin % | 0.37 | |||||
ROE % | 3.32 | |||||
ROA % | 1.87 | |||||
ROIC % | 3.65 | |||||
3-Year ROIIC % | -5.29 | |||||
ROC (Joel Greenblatt) % | 7.5 | |||||
ROCE % | 5.21 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.8 | |||||
Forward PE Ratio | 21.92 | |||||
PE Ratio without NRI | 22.23 | |||||
Price-to-Owner-Earnings | 337.5 | |||||
PEG Ratio | 3.18 | |||||
PS Ratio | 0.56 | |||||
PB Ratio | 1 | |||||
Price-to-Tangible-Book | 1.86 | |||||
Price-to-Operating-Cash-Flow | 141.57 | |||||
EV-to-EBIT | 21.85 | |||||
EV-to-Forward-EBIT | 13.38 | |||||
EV-to-EBITDA | 7.06 | |||||
EV-to-Forward-EBITDA | 9.17 | |||||
EV-to-Revenue | 0.81 | |||||
EV-to-Forward-Revenue | 0.89 | |||||
EV-to-FCF | -19.58 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 1.45 | |||||
Price-to-Median-PS-Value | 0.6 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.04 | |||||
Price-to-Graham-Number | 1.35 | |||||
Earnings Yield (Greenblatt) % | 4.58 | |||||
FCF Yield % | -7.61 | |||||
Forward Rate of Return (Yacktman) % | 7.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Laboratorio Reig Jofre SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 406.75 | ||
| EPS (TTM) (€) | 0.082 | ||
| Beta | 0.5882 | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 20.09 | ||
| 14-Day RSI | 51.59 | ||
| 14-Day ATR (€) | 0.016052 | ||
| 20-Day SMA (€) | 2.619 | ||
| 12-1 Month Momentum % | -4.06 | ||
| 52-Week Range (€) | 2.13 - 3.19 | ||
| Shares Outstanding (Mil) | 82.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Laboratorio Reig Jofre SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Laboratorio Reig Jofre SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.024000 Cash Dividend | 2026-05-21 | 2.70 (+0.00%) | ||
| EUR 0.049000 Cash Dividend | 2025-05-15 | 2.92 (+1.04%) |
Show
Entries
Laboratorio Reig Jofre SA Frequently Asked Questions
What is Laboratorio Reig Jofre SA(FRA:FEQ1)'s stock price today?
The current price of FRA:FEQ1 is €2.62. The 52 week high of FRA:FEQ1 is €3.19 and 52 week low is €2.13.
When is next earnings date of Laboratorio Reig Jofre SA(FRA:FEQ1)?
The next earnings date of Laboratorio Reig Jofre SA(FRA:FEQ1) is .
Does Laboratorio Reig Jofre SA(FRA:FEQ1) pay dividends? If so, how much?
The Dividend Yield %  of Laboratorio Reig Jofre SA(FRA:FEQ1) is 0.91% (As of Today), Highest Dividend Payout Ratio of Laboratorio Reig Jofre SA(FRA:FEQ1) was 0.59. The lowest was 0.2. And the median was 0.39. The  Forward Dividend Yield % of Laboratorio Reig Jofre SA(FRA:FEQ1) is 0.91%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Laboratorio Reig Jofre SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers